AltPep logo

AltPep

altpep.com

AltPep develops early detection tools and disease-modifying treatments for amyloid diseases, including neurodegenerative conditions and type 2 diabetes, by targeting toxic soluble oligomers. Its lead program focuses on identifying Alzheimer’s disease before symptoms appear and neutralizing the associated toxic oligomers. The organization aims to enable early screening and preventive intervention for these diseases.

Facts

HQ
Seattle, WA
Sectors
Biotechnology
Founded
2019
Type
Corporation Seattle business license
Employees
32
Registered name
AltPep Corporation Seattle business license
Stage
Series B
Members see funding amounts.
.

Is this your organization? Claim it

Five CEOs Named Finalists for GeekWire Startup CEO of the Year for Advances in Biotech, Mental Health, and E-commerce

Five finalists for the Startup CEO of the Year at the GeekWire Awards include leaders from AltPep, SEngine Precision Medicine, Joon Care, FlavorCloud, and Strella Biotechnology, each driving innovations in biotech, mental health, and e-commerce. These CEOs are recognized for advancing treatments, therapies, and international shipping solutions while raising significant funding.

See all 7 news stories about AltPep.

People

  • Valerie Daggett
    Valerie Daggett Executive Officer, Director, Promoter, Founder and CEO

Online